On Monday, August 23, the Food and Drug Administration (FDA) gave full approval for the Pfizer-BioNTech COVID-19 vaccine. The vaccine will now be marketed under the name Comirnaty and will be available to prevent the disease in individuals 16 years and older. For now, the vaccine will remain under emergency use authorization (EUA) for...
